InvestorsHub Logo
Followers 2
Posts 193
Boards Moderated 0
Alias Born 03/26/2019

Re: None

Thursday, 08/04/2022 4:51:19 PM

Thursday, August 04, 2022 4:51:19 PM

Post# of 34846
Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma
https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-announces-fda-clearance-ind-mt-601-six
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News